Dr. Thomas E. Hutson Has Been Recognized Among the Top in His Industry by the Expert Network©

The Expert Network© celebrates its newest member, Dr. Thomas E. Hutson

​​​Dr. Thomas E. Hutson, Director, Genitourinary Oncology Program, Texas Oncology, Charles A. Sammons Cancer Center, has joined The Expert Network, an invitation-only service for distinguished professionals. Dr. Hutson has been chosen as a Distinguished Doctor based on peer reviews and ratings, numerous recognitions, and accomplishments achieved throughout his career.

Dr. Hutson outshines others in his field due to his extensive educational background, numerous awards and recognitions, and career longevity. After receiving his Bachelor of Science in Pharmacy from Ohio Northern University, Dr. Hutson went on to earn his Doctor of Osteopathic Medicine from the Ohio University College of Osteopathic Medicine. He then returned to Ohio Northern University to obtain a Doctor of Pharmacy. Dr. Hutson continued his training at the Cleveland Clinic Foundation with an Internal Medicine Residency, followed by an Experimental Therapeutics Fellowship and a Hematology/Medical Oncology Fellowship. He is Board Certified in Internal Medicine (ABIM, NBPS) and Medical Oncology (ABIM, NBPS).

"My goal is to provide my patients with the latest treatment advances and clinical research."

Thomas E. Hutson, D.O., Pharm.D., Director, Genitourinary Oncology Program, Texas Oncology, Charles A. Sammons Cancer Center

With nearly 20 years dedicated to medicine, Dr. Hutson is a leading expert in the field of Genitourinary Oncology. When asked why he decided to pursue a career in medicine, Dr. Hutson said:

"I ultimately wanted to provide high-level care to patients. While I was at the beginning of my medical training, my mother was diagnosed with cancer. That influenced my decision to go into oncology."

Today, Dr. Hutson is an internationally known and respected oncologist. Specializing in Urologic cancer, he is a leading expert in kidney cancers that until about ten years ago were completely untreatable. Over the course of his training and internships, Dr. Hutson developed an interest in clinical drug development and has since been the lead international investigator in the FDA approval of nine therapies for kidney cancer.

An avid contributor to all areas of his specialty, Dr. Hutson has authored over 150 peer-reviewed papers in leading medical journals, including the New England Journal of MedicineLancetJAMA, and the Journal of Clinical Oncology. In addition to his position as a Professor of Medicine, he has been invited to speak at medical venues around the world. He also serves on the editorial board for several medical journals, including the Expert Review of Anticancer TherapyCURE MagazineClinical GU Cancer, and the Kidney Cancer Journal.

As a thought-leader in his specialty, Dr. Hutson is a widely renowned innovator and maintains a practice at the cutting-edge of medical advancements. He is the driving force behind developments in many cancer treatments, working tirelessly to provide state-of-the-art patient care. He noted:

"My goal is to provide my patients with the latest treatment advances and clinical research."

For more information, visit Dr. Hutson's profile on the Expert Network here: http://expertnetwork.co/members/thomas-e-hutson,-do,-pharmd/1485d1fb08b1c699​

The Expert Network© has written this news release with approval and/or contributions from Dr. Thomas E. Hutson. The Expert Network© is an invitation-only reputation management service that is dedicated to helping professionals stand out, network, and gain a competitive edge. The Expert Network selects a limited number of professionals based on their individual recognitions and history of personal excellence.

Source: The Expert Network©

Related Media

About Noticed©

Noticed© is a professional success database, featuring the stories of doctors, lawyers, dentists, wealth managers and other professionals who have succeeded and helping them achieve continued success.

17505 N 79th Ave , #Ste 301C
Glendale, AZ


More Press Releases